• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Vital Therapies

edit

Vital Therapies, Inc. (VTI) is targeting the treatment of liver disease and is developing the first human liver cell-based ELAD® which is in investigational clinical trials in USA and China.

Milestones

edit

• 
  Vital Therapies added Ross A. Jaffe as Director.
  Posted 12/10/09 at 7:19pm
• 
  Vital Therapies added Charles Liamos as Director.
  Posted 12/10/09 at 7:16pm
• 
  Vital Therapies received $4.35M in Venture Round funding. (2/2/12)
  Posted 4/13/12 at 4:08am
• 
  Vital Therapies received $229k in Venture Round funding. (12/10/09)
  Posted 12/10/09 at 7:10pm via sec.gov
• 
  Vital Therapies received $90.4k in Venture Round funding. (10/28/09)
  Posted 12/10/09 at 7:10pm via sec.gov
• 
  Vital Therapies received $3.65M in Venture Round funding. (10/7/09)
  Posted 12/10/09 at 7:10pm via sec.gov

Videos

Screenshots

edit

Above: Home Page
Uploaded: 3/29/10

Sources

1. SEC D (sec.gov) [edit]
2. SEC D/A (sec.gov) [edit]
3. SEC D/A (sec.gov) [edit]
4. DFJ report [edit]